US Patent Issued to Abbott Diabetes Care on Sept. 30 for "Analyte monitoring and management device and method to analyze the frequency of user interaction with the device" (British, American Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,426,812, issued on Sept. 30, was assigned to Abbott Diabetes Care Inc. (Alameda, Calif.).

"Analyte monitoring and management device and method to analyze the frequency of user interaction with the device" was invented by Marc Barry Taub (Mountain View, Calif.), Jolyon Robert Bugler (Combe, Great Britain) and Thomas A. Peyser (Menlo Park, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods and Devices to monitor the level of at least one analyte are provided."

The patent was filed on May 16, 2024, under Application No. 18/666,331.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-...